From: Does route of administration affect the outcome of TNF antagonist therapy?
Route | Advantages |
---|---|
Subcutaneous | Patient control |
 | Lack of associated (such as office-related) costs |
 | No need for patient to travel to office |
Intravenous | Physician control |
 | Automatic compliance |
 | Dose not limited by volume |
 | Continuous titration available |
 | Rapid onset of action |
 | Reimbursed by Medicare |